Jeff represents clients in patent litigation and other intellectual property issues, including some of the world's preeminent life sciences, pharmaceutical, biotech and high-tech companies. He has extensive experience guiding clients through all phases of complex patent litigation, including Hatch-Waxman patent litigation, inter partes reviews at the U.S. Patent Office and appeals to the U.S. Court of Appeals for the Federal Circuit.
Jeff has been lead counsel on several high-profile patent infringement disputes as well as arbitrations on patent licensing issues, and has achieved a string of significant victories for his clients. An important part of his practice is counseling his clients prior to litigation on issues concerning patentability, patent clearance and licensing. Jeff has also developed a significant track record litigating matters and counseling clients in the electrical arts, including mobile communications, internet applications, semiconductor devices and hardware and software inventions.
In 2021, Jeff was honored by The Best Lawyers in America for his excellence in patent litigation. Jeff has also been consistently ranked by IAM Patent 1000 as a leading patent practitioner (2012 – 2022). Additionally, he has been recognized as a Patent Star by Managing Intellectual Property and a Life Sciences Star by LMG Life Sciences. Jeff has also been highly regarded by The Legal 500 for his handling of cases involving the Hatch-Waxman Act and for his IP work in media, technology and telecoms, and life sciences. The Benchmark Litigation Guide has also recognized Jeff as a Litigation Star. In 2014, Jeff was awarded Lawyer of the Year for Patent Litigation in New York. He is regularly sought after for his cutting-edge knowledge and frequently writes and lectures on patent law as well as other IP-related issues.
Prior to joining Fenwick, Jeff was a partner in the IP group at a leading international law firm.